Back to search
Women Receiving Chemotherapy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Women Receiving Chemotherapy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Women Receiving Chemotherapy trials you may qualify forThe main purpose of this study is to compare the disease-free survival (the length of time after randomization that a participant survives without any signs or…
This phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypof…
The overall purpose of this study is to investigate whether younger subjects report pain with pegfilgrastim (or biosimilar substitution) more often and/or at hi…
this is a trial evaluating three chemotherapy agents in patients with newly diagnosed ovarian cancer patients that are Stage III or Stage IV prior to surgery to…
This is a phase II single-arm, Phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining efficacy of riluzole in preventing cogn…
The purpose of this research is to determine whether a 16-week virtually supervised aerobic and resistance exercise program is feasible in patients receiving fi…
The purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder canc…
This is a phase I, dose-escalation and phase II dose-expansion clinical trial determining the maximum tolerated dose (MTD) and safety and tolerability of adding…